Potassium trifluoro(trans-2-methylcyclohexyl)borate, 95.0%, 25g

2-Chloro-4-fluoro-benzamidine hydrochloride, 97.0%, 1g

(2e)-3-(Quinolin-6-yl)prop-2-enoic acid, 98%, 5g

1-Boc-4-Methylpiperazine, 95.0%, 10g

Pentafluorobenzoic acid, 98.0%, 5g

1-(4-Methoxypyrimidin-2-yl)piperidine-4-carboxylic acid, 98%, 250mg

GC capillary column ROTI®Cap-1, 50 m, 0.53 mm, 5.00 µm, 1 Piece(s)

7-Methoxy-4-methyl-2,3,4,5-tetrahydrobenzo[f][1,4]thiazepine, 95.0%, 50mg

tert-Butyl (3S,4R)-3-(hydroxymethyl)-4-(4-methoxyphenyl)pyrrolidine-1-carboxylate, 95.0%, 250mg

1-Iodobutane (stabilized with Copper chip)>98.0%(GC)500g

5-Bromo-2-chloro-4-hydroxypyridine, 95.0%, 5g

Methyl({4-[(morpholin-4-yl)methyl]phenyl}methyl)amine, 98%, 250mg

4-Chloro-2-iodobenzoic Acid>98.0%(T)1g